Clinical trial

Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With…

NCT00068068 · Light Sciences LLC, Industry · Completed

Key facts

NCT number NCT00068068
Title Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases
Official title Safety and Efficacy of Treating Refractory Cancers With the Litx™ System: Phase II Safety and Efficacy Study in Patients With Liver Metastases From Colorectal Cancer That Have Failed Chemotherapy
Lead sponsor Light Sciences LLC, Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Liver Metastasis, Colorectal Neoplasms, Liver Neoplasms, Neoplasm Metastasis
Intervention type Device, Drug, Procedure
Interventions Talaporfin sodium (LS11), LED-based light infusion device, Light emitting diodes (LED), Photodynamic therapy, Phototherapy, Chemotherapy
Enrollment 25
Start date Oct 1, 2003
First posted Sep 8, 2003
Last update posted Sep 19, 2006
Countries Germany, United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies